吉林大学第一医院

The Department of Cardiology at Jilin University First Hospital is a national key clinical specialty with over 60 years of history. It integrates clinical care, scientific research, and teaching, operating one of Northeast China's largest cardiac catheterization laboratories and a dedicated arrhythmia center. The department specializes in minimally invasive interventions, structural heart disease correction, and advanced heart failure management. Its multidisciplinary team includes 12 senior cardiologists certified by the American College of Cardiology and European Society of Cardiology. The department actively participates in national multicenter trials and has published over 200 peer-reviewed papers in high-impact journals. With round-the-clock STEMI response capability and a dedicated cardiac ICU, it delivers rapid, evidence-based care for complex cardiovascular conditions across all age groups.

Renowned as a national neurosurgical training base and key discipline of Jilin Province, this department excels in treating complex brain and spinal disorders using cutting-edge techniques. It houses a dedicated intraoperative MRI suite, neuronavigation platform, and robotic-assisted surgery system. The team performs over 1,800 craniotomies annually—including awake craniotomies for glioma resection—and leads regional stroke and traumatic brain injury networks. Research focuses on glioblastoma molecular profiling, neuroendovascular therapeutics, and neural regeneration. Faculty hold leadership roles in the Chinese Neurosurgical Society and regularly host international workshops. With strict quality control protocols and real-time neuromonitoring, outcomes consistently exceed national benchmarks for both elective and emergency neurosurgical interventions.

As a National Clinical Key Specialty and WHO Collaborating Center for Hematology, this department pioneers precision diagnostics and targeted therapies for hematologic malignancies and rare blood disorders. It operates Northeast China’s first accredited CAR-T cell therapy manufacturing facility and a comprehensive bone marrow transplant unit with over 300 annual allogeneic transplants. The team utilizes next-generation sequencing, flow cytometry, and digital PCR to guide individualized treatment plans. Clinical trials include novel bispecific antibodies, epigenetic modulators, and MRD-guided consolidation strategies. The department also manages China’s largest registry for immune thrombocytopenia and hereditary hemoglobinopathies. With integrated psychosocial support and long-term survivorship programs, it ensures holistic, patient-centered care from diagnosis through remission.

This nationally recognized orthopedic center combines biomechanical engineering expertise with clinical excellence in joint reconstruction, spine surgery, sports medicine, and trauma care. It serves as the Northeast Regional Trauma Center and hosts a state-of-the-art gait analysis laboratory and 3D-printing surgical planning suite. The department performs over 4,500 joint replacements yearly—including robotic-arm assisted total knee arthroplasty—and leads national guidelines for osteoporotic fracture prevention. Its spine division specializes in minimally invasive deformity correction and artificial disc replacement. Research collaborations with Jilin University’s School of Materials Science have yielded FDA-cleared bioactive implants. Multidisciplinary rehabilitation pathways, same-day discharge protocols, and AI-powered post-op monitoring ensure accelerated functional recovery and reduced complication rates.

A National Key Clinical Discipline and designated National Digestive Disease Clinical Research Center, this department delivers comprehensive care for inflammatory bowel disease, hepatobiliary malignancies, pancreatic disorders, and early gastrointestinal cancers. Its endoscopy center performs over 65,000 procedures annually—including confocal laser endomicroscopy, ERCP with cholangioscopy, and submucosal tunneling dissection—and maintains the highest adenoma detection rate in Northeast China. The liver transplantation program, launched in 2010, has achieved >90% 1-year graft survival. The department co-leads the China IBD Consortium and developed the nationally adopted 'JLU-GI Risk Stratification Model' for predicting Crohn’s disease progression. With integrated pathology, radiology, and nutrition support, it offers seamless, pathway-driven care across the full GI disease spectrum.

Designated as a National Clinical Key Specialty and National Respiratory Disease Clinical Research Center, this department provides advanced diagnostics and therapeutics for chronic airway diseases, interstitial lung disease, pulmonary hypertension, and critical respiratory failure. It operates one of China’s largest extracorporeal membrane oxygenation (ECMO) programs for refractory ARDS and pioneered the use of adaptive servo-ventilation for obesity-hypoventilation syndrome. The department’s interstitial lung disease clinic integrates high-resolution CT radiomics, bronchoalveolar lavage proteomics, and genetic testing to refine idiopathic pulmonary fibrosis classification. Its COPD management program reduced hospital readmissions by 42% through AI-driven remote monitoring and personalized pulmonary rehabilitation. Faculty contribute to GOLD and ATS guidelines and lead multiple Phase III trials of novel antifibrotic and anti-inflammatory agents.